Skip to main content
DIMERIX LIMITED logo

DIMERIX LIMITED — Investor Relations & Filings

Ticker · DXB ISIN · AU000000DXB7 ASX Professional, scientific and technical activities
Open in API
Filings indexed 1,124 across all filing types
Latest filing 2009-09-30 Director's Dealing
Country AU Australia
Listing ASX DXB

About DIMERIX LIMITED

https://dimerix.com/

Dimerix Limited focuses on the development of therapeutic treatments for inflammatory diseases, with a primary emphasis on kidney and respiratory conditions. The company utilizes its proprietary Receptor-Heteromer Investigation Technology (DMX-Technology) to identify and validate G protein-coupled receptor (GPCR) targets. Its lead candidate, DMX-200, is a chemokine receptor (CCR2) antagonist currently in Phase 3 clinical trials for the treatment of Focal Segmental Glomerulosclerosis (FSGS). The company is also advancing DMX-700 for Chronic Obstructive Pulmonary Disease (COPD) and exploring applications for diabetic kidney disease. The core strategy involves targeting multiple signaling pathways simultaneously to address unmet medical needs in chronic inflammatory and fibrotic diseases.

Recent filings

Filing Released Lang Actions
Initial Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X' and is an 'Initial Director’s Interest Notice' filed under ASX listing rule 3.19A.1. It details the director's relevant interests in securities and contracts, specifically noting NIL holdings and contracts. This type of document is a report of personal share transactions or interests by company directors. It is not a financial report, earnings release, or management report. It fits the definition of 'Director's Dealing' filings, which report personal share transactions or interests by directors and executives.
2009-09-30 English
Expiry of Options 1 page ?Kb
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the expiry of options for Sun Biomedical Limited. It does not contain financial statements, detailed financial data, or management discussion. It is a regulatory announcement about a capital instrument (options) expiring, which relates to capital structure but is not a full financing update or capital raising. Given the brevity and nature of the content, it fits best under Regulatory Filings (RNS) as a general announcement that does not fit other specific categories.
2009-09-13 English
Change of Directors 1 page ?Kb
Board/Management Information Classification · 100% confidence The document is an ASX company announcement dated 2 September 2009 regarding changes to the company's board of directors. It announces the appointment of a new Non-Executive Director and Chairman-elect, the replacement of the current Chairman, and the resignation of another Non-Executive Director. There is no financial data, no mention of a report or financial results, and the content focuses solely on management changes. The document length is short (1930 characters), and it is clearly an announcement of board/management changes rather than a report or other filing type. Therefore, the appropriate classification is Board/Management Information (MANG).
2009-09-01 English
Final Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Z Final Director’s Interest Notice' and references ASX listing rule 3.19A.3 and section 205G of the Corporations Act. It details the director's relevant interests in securities, including shares and options, and notes the date the director ceased to be a director. This is a report of personal share transactions and holdings by a company director, which aligns with the definition of Director's Dealing filings. The document length is short and focused solely on director interests, with no financial performance or management discussion, so it is not an annual report or earnings release. Therefore, the correct classification is Director's Dealing (DIRS).
2009-09-01 English
Initial Director`s Interest Notice 2 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the director's relevant interests in securities and contracts, with no securities held or contracts disclosed. This matches the description of a Director's Dealing report, which involves reporting personal share transactions or interests by company directors. The document length is short and contains specific director interest information, not a general announcement or other report type.
2009-09-01 English
Annual Report to shareholders 65 pages ?Kb
Regulatory Filings
2009-08-31 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.